Literature DB >> 12788423

Colorectal adenocarcinoma in cirrhotic patients.

Pascal Gervaz1, Rattaplee Pak-art, Santhat Nivatvongs, Bruce G Wolff, Dirk Larson, Stacie Ringel.   

Abstract

BACKGROUND: Colorectal carcinoma in cirrhotic patients is different from that in patients without the liver disease. The aims of this study were to evaluate the incidence of liver metastasis, postoperative mortality, and the predictors of longterm survival. STUDY
DESIGN: A retrospective analysis of patients operated on for colorectal adenocarcinoma at the Mayo Clinic, Rochester, MN between 1976 and 2001, with confirmed liver cirrhosis at the time of abdominal exploration.
RESULTS: Seventy-two patients were available for analysis. They were 43% Child A, 42% Child B, and 15% Child C. The median age was 70 (range 42 to 89) years, and the mean duration of followup was 46 months. Postoperative death was 13%. The risk factors were an elevated bilirubin (p = 0.01) and prolonged prothrombin time (p = 0.009). Seven patients (10%) developed liver metastases. For the whole group 1-, 3-, and 5-year survival rates were 69%, 49%, and 35%, respectively. Child A patients had a significantly better survival rate than the combined group of Child B and C patients (p = 0.008). The risks for longterm survival were decreased albumin (p = 0.002) and prolonged prothrombin time (p < 0.001). TNM stage of the carcinoma provided no prognostic information (p = 0.51).
CONCLUSIONS: Liver metastases from colorectal adenocarcinoma is infrequent (10%) in cirrhotic patients. The Child's classification, and not the TNM stage of the carcinoma, predicts the risk of postoperative death and longterm survival.

Entities:  

Mesh:

Year:  2003        PMID: 12788423     DOI: 10.1016/S1072-7515(03)00117-0

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  15 in total

Review 1.  Molecular biology of cancer-associated fibroblasts: can these cells be targeted in anti-cancer therapy?

Authors:  Tamas A Gonda; Andrea Varro; Timothy C Wang; Benjamin Tycko
Journal:  Semin Cell Dev Biol       Date:  2009-10-17       Impact factor: 7.727

2.  Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma?

Authors:  Massimo Galia; Adele Taibbi; Daniele Marin; Alessandro Furlan; Marco Dioguardi Burgio; Francesco Agnello; Giuseppe Cabibbo; Bernard E Van Beers; Tommaso Vincenzo Bartolotta; Massimo Midiri; Roberto Lagalla; Giuseppe Brancatelli
Journal:  Diagn Interv Radiol       Date:  2014 May-Jun       Impact factor: 2.630

3.  Factors affecting the postoperative morbidity and survival of patients with liver cirrhosis following colorectal cancer surgery.

Authors:  Jun Ho Lee; Chang Sik Yu; Jong Lyul Lee; Chan Wook Kim; Yong Sik Yoon; In Ja Park; Seok-Byung Lim; Jin Cheon Kim
Journal:  Int J Colorectal Dis       Date:  2016-12-16       Impact factor: 2.571

4.  Gastric cancer surgery in cirrhotic patients: result of gastrectomy with D2 lymph node dissection.

Authors:  Jun Ho Lee; Junuk Kim; Jae Ho Cheong; Woo Jin Hyung; Seung Ho Choi; Sung Hoon Noh
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

5.  Coexisting liver disease is associated with increased mortality after surgery for diverticular disease.

Authors:  Jonathan Montomoli; Rune Erichsen; Lisa L Strate; Lars Pedersen; Tove Nilsson; Henrik Toft Sørensen
Journal:  Dig Dis Sci       Date:  2015-01-06       Impact factor: 3.199

6.  The liver prometastatic reaction of cancer patients: implications for microenvironment-dependent colon cancer gene regulation.

Authors:  Fernando Vidal-Vanaclocha
Journal:  Cancer Microenviron       Date:  2011-08-26

7.  Hepatic steatosis is associated with lower incidence of liver metastasis from colorectal cancer.

Authors:  Koji Murono; Joji Kitayama; Nelson H Tsuno; Hiroaki Nozawa; Kazushige Kawai; Eiji Sunami; Masaaki Akahane; Toshiaki Watanabe
Journal:  Int J Colorectal Dis       Date:  2013-02-08       Impact factor: 2.571

8.  Hepatocellular carcinoma incidentally detected at second hepatectomy for repeated colorectal liver metastasis in a patient with hepatitis C virus-related cirrhosis: a case report.

Authors:  Atsuo Kobayashi; Daisuke Morioka; Chizuru Matsumoto; Yasuhiko Miura; Masaru Miura
Journal:  J Med Case Rep       Date:  2016-05-27

9.  Liver disease and 30-day mortality after colorectal cancer surgery: a Danish population-based cohort study.

Authors:  Jonathan Montomoli; Rune Erichsen; Christian Fynbo Christiansen; Sinna Pilgaard Ulrichsen; Lars Pedersen; Tove Nilsson; Henrik Toft Sørensen
Journal:  BMC Gastroenterol       Date:  2013-04-15       Impact factor: 3.067

Review 10.  Colorectal surgery in cirrhotic patients.

Authors:  Jacqueline Paolino; Randolph M Steinhagen
Journal:  ScientificWorldJournal       Date:  2014-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.